Shailendra K Saxena

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 27

Top Topics

Respiratory Syndrome Coronavirus

Helicobacter Pylori

Juvenile Idiopathic Arthritis

Top Venues

Journal of medical virology

Human vaccines & immunotherapeutics

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Madhu Khanna, Kajal Sharma, Shailendra K Saxena, Jai Gopal Sharma, Roopali Rajput, Binod Kumar
Unravelling the interaction between Influenza virus and the nuclear pore complex: insights into viral replication and host immune response. Virusdisease 35 (2) (2024)
Madhu Khanna, Kajal Sharma, Shailendra K Saxena, Jai Gopal Sharma, Roopali Rajput, Binod Kumar
Unravelling the interaction between Influenza virus and the nuclear pore complex: insights into viral replication and host immune response. Virusdisease 35 (2) (2024)
Vimal K Maurya, Swatantra Kumar, Saniya Ansari, Amod K Sachan, Umashankar Singh, Janusz T Paweska, Ahmed S Abdel-Moneim, Shailendra K Saxena
Antiviral and anti-inflammatory activity of natural compounds against Japanese encephalitis virus via inhibition of NS5 protein and regulation of key immune and inflammatory signaling pathways. Journal of medical virology (2023)
Tushar Yadav, Swatantra Kumar, Gourav Mishra, Shailendra K Saxena
Tracking the COVID-19 vaccines: The global landscape. Human vaccines & immunotherapeutics (2023)
Abhishek Padhi, Ashwini Agarwal, Shailendra K Saxena, C D S Katoch
Transforming clinical virology with AI, machine learning and deep learning: a comprehensive review and outlook. Virusdisease 34 (3) (2023)
Shailendra K Saxena, Swatantra Kumar, Vimal K Maurya, Debadatta Nayak, Subhash Kaushik, Raj K Manchanda, Srinivasulu Gadugu
Antiviral and anti-inflammatory activity of novel belladonna formulation against Japanese encephalitis virus via inhibition of p65 nuclear translocation and TNF-α mediated NF-kB signaling. Biotechnology & genetic engineering reviews (2023)
Shailendra K Saxena, Swatantra Kumar, Vimal K Maurya, Debadatta Nayak, Subhash Kaushik, Raj K Manchanda, Srinivasulu Gadugu
Antiviral and anti-inflammatory activity of novel belladonna formulation against Japanese encephalitis virus via inhibition of p65 nuclear translocation and TNF-α mediated NF-kB signaling. Biotechnology & genetic engineering reviews (2023)
Shailendra K Saxena, Deepak Sharma, Swatantra Kumar, Bipin Puri
Understanding HIV-associated neurocognitive and neurodegenerative disorders (neuroAIDS): enroute to achieve the 95-95-95 target and sustainable development goal for HIV/AIDS response. Virusdisease 34 (2) (2023)
Supriya Roy, Suneela Dhaneshwar, Tarique Mahmood, Swatantra Kumar, Shailendra K Saxena
Pre-clinical investigation of protective effect of nutraceutical D-glucosamine on TNBS-induced colitis. Immunopharmacology and immunotoxicology (2022)
Shailendra K Saxena, Swatantra Kumar, Saniya Ansari, Janusz T Paweska, Vimal K Maurya, Anil K Tripathi, Ahmed S Abdel-Moneim
Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus-2 Omicron Variant of Concern. Journal of medical virology 94 (5) (2022)
Nagendra Thakur, Sayak Das, Swatantra Kumar, Vimal K Maurya, Kuldeep Dhama, Janusz T Paweska, Ahmed S Abdel-Moneim, Amita Jain, Anil K Tripathi, Bipin Puri, Shailendra K Saxena
Tracing the origin of Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A systematic review and narrative synthesis. Journal of medical virology 94 (12) (2022)
Shailendra K Saxena, Swatantra Kumar, Saniya Ansari, Janusz T Paweska, Vimal K Maurya, Anil K Tripathi, Ahmed S Abdel-Moneim
Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. Journal of medical virology 94 (4) (2022)
Narayan Chaudhary, Gourav Mishra, Tushar Yadav, Nishant Srivastava, Vimal K Maurya, Shailendra K Saxena
Fabrication and Evaluation of Basil Essential Oil-Loaded Halloysite Nanotubes in Chitosan Nanocomposite Film and Its Application in Food Packaging. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Shailendra K Saxena, Saniya Ansari, Vimal K Maurya, Swatantra Kumar, Amita Jain, Janusz T Paweska, Anil K Tripathi, Ahmed S Abdel-Moneim
Re-emerging human monkeypox: A major public-health debacle. Journal of medical virology (2022)
Narayan Chaudhary, Gourav Mishra, Tushar Yadav, Nishant Srivastava, Vimal K Maurya, Shailendra K Saxena
Fabrication and Evaluation of Basil Essential Oil-Loaded Halloysite Nanotubes in Chitosan Nanocomposite Film and Its Application in Food Packaging. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Radha Kanta Ratho, Radha Kanta Ratho, Pradeep Kumar, Shashi Kant Bhatia, Ishani Bora, Gursimran Kaur Mohi, Shailendra K Saxena, Manju Devi, Dhananjay Yadav, Sanjeet Mehariya
Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations. Journal of clinical medicine 10 (3) (2021)
Kuldeep Dhama, Senthilkumar Natesan, Mohammad Iqbal Yatoo, Shailesh Kumar Patel, Ruchi Tiwari, Shailendra K Saxena, Harapan Harapan
Plant-based vaccines and antibodies to combat COVID-19: current status and prospects. Human vaccines & immunotherapeutics 16 (12) (2020)
Ankur Gupta, Rashmi Karki, Himanshu R Dandu, Kuldeep Dhama, Madan Lb Bhatt, Shailendra K Saxena
COVID-19: benefits and risks of passive immunotherapeutics. Human vaccines & immunotherapeutics 16 (12) (2020)
Vimal K Maurya, Swatantra Kumar, Russell Kabir, Gaurav Shrivastava, Karuna Shanker, Debadatta Nayak, Anil Khurana, Raj K Manchanda, Srinivasulu Gadugu, Sujita K Kar, Anoop K Verma, Shailendra K Saxena
Dark Classics in Chemical Neuroscience: An Evidence-Based Systematic Review of Belladonna. ACS chemical neuroscience (2020)
Tushar Yadav, Nishant Srivastava, Gourav Mishra, Kuldeep Dhama, Swatantra Kumar, Bipin Puri, Shailendra K Saxena
Recombinant vaccines for COVID-19. Human vaccines & immunotherapeutics 16 (12) (2020)
Kuldeep Dhama, Shailesh Kumar Patel, Senthilkumar Natesan, Kranti Suresh Vora, Mohammad Iqbal Yatoo, Ruchi Tiwari, Shailendra K Saxena, Karam Pal Singh, Rajendra Kumar Singh, Yashpal Singh Malik
COVID-19 in the elderly people and advances in vaccination approaches. Human vaccines & immunotherapeutics 16 (12) (2020)
Shailendra K Saxena, Swatantra Kumar, Preeti Baxi, Nishant Srivastava, Bipin Puri, R K Ratho
Chasing COVID-19 through SARS-CoV-2 spike glycoprotein. Virusdisease (2020)
Swatantra Kumar, Vimal K Maurya, Anil K Prasad, Madan L B Bhatt, Shailendra K Saxena
Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). Virusdisease 31 (1) (2020)
Swatantra Kumar, Vimal K Maurya, Russell Kabir, Debadatta Nayak, Anil Khurana, Raj K Manchanda, Srinivasulu Gadugu, Karuna Shanker, Shailendra K Saxena
Antiviral Activity of Belladonna During Japanese Encephalitis Virus Infection via Inhibition of Microglia Activation and Inflammation Leading to Neuronal Cell Survival. ACS chemical neuroscience 11 (21) (2020)
Shailja Mishra, Vimal K Maurya, Swatantra Kumar, null Ankita, Apjit Kaur, Shailendra K Saxena
Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives. Current eye research 45 (11) (2020)
Vimal K Maurya, Swatantra Kumar, Madan L B Bhatt, Shailendra K Saxena
Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection. Journal of biomolecular structure & dynamics (2020)
Shailendra K Saxena, Asif Elahi, Srinivasulu Gadugu, Anil K Prasad
Zika virus outbreak: an overview of the experimental therapeutics and treatment. Virusdisease 27 (2) (2016)